MedPath

(KIWI) Speeding up a Slow Protein for Muscle Mass With Hay Kiwifruit

Not Applicable
Completed
Conditions
Metabolism
Protein
Interventions
Dietary Supplement: Green Hayward Kiwifruit first, then Gold Kiwifruit
Dietary Supplement: Gold Kiwifruit First, then Green Hayward Kiwifruit
Registration Number
NCT04356573
Lead Sponsor
University of Arkansas
Brief Summary

The specific hypothesis is that the consumption of 2 Hayward green kiwifruit (containing actinidin protease) prior to 100g of ground beef will increase the rate of protein digestion from the beef in the elderly, leading to an increased uptake of the essential amino acids. Furthermore, this increased essential amino acid availability will produce a greater postprandial net anabolic protein response, as well as increased fractional synthetic rates of muscle proteins.

Detailed Description

The specific hypothesis is that the consumption of 2 Hayward green kiwifruit (containing actinidin protease) prior to 100g of ground beef will increase the rate of protein digestion from the beef in the elderly, leading to an increased uptake of the essential amino acids. Furthermore, this increased essential amino acid availability will produce a greater postprandial net anabolic protein response, as well as increased fractional synthetic rates of muscle proteins.

To test this hypothesis, the investigators will use a double-blinded crossover design involving two intervention arms; in both arms 100g of ground beef (cooked weight) will be consumed following either 2 Hayward green kiwifruit (containing actinidin protease) or 2 Hort16A Gold kiwifruit (devoid of actinidin protease) by elderly subjects.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • men and women ages 60-85 inclusive.
Exclusion Criteria
  • Inability to chew meats or difficulty swallowing solid foods
  • History of diabetes
  • History of malignancy in the 6 months prior to enrolment
  • History of gastrointestinal reduction or bypass surgery (Lapband, etc)
  • History of a chronic inflammatory condition or disease (Lupus, HIV'AIDS, etc)
  • History of chronic kidney disease or currently requiring dialysis.
  • Allergy to beef or kiwifruit
  • Subjects who do not or will not eat animal proteins
  • Subjects who cannot refrain from consuming protein or amino acid supplements during their participation in this study
  • Subjects who report regular resistance exercise (more than once per week)
  • Hemoglobin less than 9.5mg/dL at the screening visit
  • Platelets less than <150,000 at the screening visit
  • Subjects who are not willing or able to suspend aspirin for several days prior to their muscle biopsies.
  • Subjects who have been prescribed a blood-thinning medication (Coumadin, lovenox, heparin, Plavix, etc).
  • Concomitant use of corticosteroids (ingestion, injection or transdermal)
  • Any other disease or condition that would place the subject at increased risk of harm if they were to participate, at the discretion of the study physician

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Gold Kiwifruit First, then Green Hayward KiwifruitGold Kiwifruit First, then Green Hayward KiwifruitSubjects first ate 2 gold kiwifruit with midday meal for 2 weeks before crossing over to the green Hayward kiwifruit intervention
Green Hayward Kiwifruit first, then Gold KiwifruitGreen Hayward Kiwifruit first, then Gold KiwifruitSubjects first ate 2 green Hayward kiwifruit with midday meal for 2 weeks before crossing over to the gold kiwifruit intervention
Gold Kiwifruit First, then Green Hayward KiwifruitGreen Hayward Kiwifruit first, then Gold KiwifruitSubjects first ate 2 gold kiwifruit with midday meal for 2 weeks before crossing over to the green Hayward kiwifruit intervention
Green Hayward Kiwifruit first, then Gold KiwifruitGold Kiwifruit First, then Green Hayward KiwifruitSubjects first ate 2 green Hayward kiwifruit with midday meal for 2 weeks before crossing over to the gold kiwifruit intervention
Primary Outcome Measures
NameTimeMethod
Whole Body Net Balance Measured by Gas Chromatography-Mass Spectrometry (GC-MS)300 minutes

Blood samples were analyzed to quantify the appearance of the stable isotopes: 2H2-tyrosine, 2H4-tyrosine, and 2H5-phenylalanine in tracer to tracee ratio or mole percent excess. Changes in these markers over time enable the calculation of whole body protein metabolism. Calculations are done as follows:

Total plasma rate of appearance = infusion rate/enrichment Fractional rate of appearance of tyrosine from phenylalanine= 2H4-tyrosine/2H5-phenylalanine Phenylalanine hydroxylation = fractional rate of appearance of tyrosine from phenylalanine x rate of appearance of tyrosine Protein Synthesis = \[(rate of appearance of phenylalanine -Phe hydroxylation) x 25\] Protein Breakdown = \[(rate of appearance of phenylalanine - phenylalanine infusion rate) x 25 - phenylalanine intake\] Net Balance = Protein Synthesis - Protein Breakdown

Secondary Outcome Measures
NameTimeMethod
Change in Skeletal Muscle Protein Metabolism Measured by Gas Chromatography-Mass Spectrometry (GC-MS)9.5 hours

Muscle samples were analyzed to quantify the appearance of the stable isotope 2H5-phenylalanine in trace to tracee ratio or mole percent excess. The change in 2H5-phenylalanine in subsequent muscle biopsy allow for the calculation of muscle protein synthesis. The calculation is done as follows: \[(2H5-phenylalanine enrichment in second biopsy - 2H5-phenylalanine enrichment in second biopsy)/ (2H5-phenylalanine plasma enrichment × time)\] × 60 × 100.

Trial Locations

Locations (1)

UAMS Center on Aging

🇺🇸

Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath